Drug Information
Quick Links
Dictionary
Funding Opportunities
NCI Publications
NCI Calendar
Español
NCI Highlights
October is Breast Cancer Awareness Month
NCI Annual Progress Report on Cancer Research 2003
Women, Tobacco and Cancer: Agenda for 21st Century
Past Highlights
Specific Drugs
Gleevec (STI571)
Herceptin
Tamoxifen: Questions and Answers
Drug Development and Approval
Understanding the Approval Process for New Cancer Treatments
A look at how the U.S. Food and Drug Administration relies on the results of clinical trials to ensure the safety and effectiveness of new cancer treatments before they go on the market.
Newly Approved Cancer Treatments
Information from the U.S. Food and Drug Administration (FDA) about recently approved cancer treatments.
Approved Oncology Drugs
Information related to approved oncology drugs, oncology drug approval processes, regulatory information and other oncology drug resources.
FDA Home Page
Cancer Liaison Program
Answers questions from the public about drug approval processes, cancer clinical trials, and access to investigational therapies.
Center for Drug Evaluation and Research
Electronic Orange Book of Approved Drug Products
Guidance Documents for Industry
Contains an archive of documents describing FDA policies on specific topics.
Industry Collaboration
Provides information to industry on the process for getting new drugs into clinical trials.
Investigator's Handbook
Provides information to investigators on specific procedures related to clinical trial development.
Questions and Answers About NCI's Natural Products Branch
A fact sheet that describes the functions of this branch, which collects and analyzes specimens of plant, marine, and microbial origin for possible anticancer properties.
Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Site Help
|
Site Map
A Service of the National Cancer Institute